Literature DB >> 8670065

Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

S L Meyer1, D Bozyczko-Coyne, S K Mallya, C M Spais, R Bihovsky, J K Kaywooya, D M Lang, R W Scott, R Siman.   

Abstract

Calpain I is a heterodimeric protein that is part of a family of calcium-activated intracellular cysteine proteases presumed to play a role in mediating signals transduced by calcium. Expression of bioactive recombinant human calpain I has been achieved using the baculovirus expression system, by either co-infection with two viruses, each expressing one of the subunits, or infection with a single virus containing both subunits. The approximately 80 kDa catalytic subunit exhibited calcium-dependent proteolytic activity when expressed alone or with the approximately 30 kDa regulatory subunit. Baculoviral recombinant calpain I appeared fully active in that the catalytic subunit in unpurified cell extracts exhibited calcium-dependent autocatalytic cleavage at the correct locus. The amount of approximately 80 kDa subunit accumulated at steady state was greatly increased by co-expression of the approximately 30 kDa subunit, suggesting a possible role for enzyme stabilization by the latter subunit. The recombinant human calpain I was purified to near homogeneity and compared with purified native human erythrocyte calpain I. The recombinant and native enzymes had equivalent inhibition constants for structurally diverse calpain inhibitors, identical calcium activation profiles, and similar specific activities, demonstrating the suitability of using the recombinant protein for studies of the native enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670065      PMCID: PMC1217080          DOI: 10.1042/bj3140511

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

Review 1.  Calcium-activated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function.

Authors:  K Suzuki; S Imajoh; Y Emori; H Kawasaki; Y Minami; S Ohno
Journal:  FEBS Lett       Date:  1987-08-17       Impact factor: 4.124

2.  Limited autolysis of calcium-activated neutral protease (CANP): reduction of the Ca2+-requirement is due to the NH2-terminal processing of the large subunit.

Authors:  S Imajoh; H Kawasaki; K Suzuki
Journal:  J Biochem       Date:  1986-09       Impact factor: 3.387

Review 3.  The calpains.

Authors:  E Melloni; S Pontremoli
Journal:  Trends Neurosci       Date:  1989-11       Impact factor: 13.837

4.  Calpain dissociates into subunits in the presence of calcium ions.

Authors:  T Yoshizawa; H Sorimachi; S Tomioka; S Ishiura; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1995-03-08       Impact factor: 3.575

5.  Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites.

Authors:  Y Emori; H Kawasaki; S Imajoh; K Imahori; K Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Complete amino acid sequence of the large subunit of the low-Ca2+-requiring form of human Ca2+-activated neutral protease (muCANP) deduced from its cDNA sequence.

Authors:  K Aoki; S Imajoh; S Ohno; Y Emori; M Koike; G Kosaki; K Suzuki
Journal:  FEBS Lett       Date:  1986-09-15       Impact factor: 4.124

7.  The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.

Authors:  C Crawford; R W Mason; P Wikstrom; E Shaw
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

8.  Inhibition of aminopeptidases by peptides containing ketomethylene and hydroxyethylene amide bond replacements.

Authors:  S L Harbeson; D H Rich
Journal:  J Med Chem       Date:  1989-06       Impact factor: 7.446

9.  The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain).

Authors:  J Cong; D E Goll; A M Peterson; H P Kapprell
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

10.  High level expression of nonfused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors.

Authors:  V A Luckow; M D Summers
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

View more
  9 in total

1.  Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division.

Authors:  J S Arthur; J S Elce; C Hegadorn; K Williams; P A Greer
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Purification of native p94, a muscle-specific calpain, and characterization of its autolysis.

Authors:  K Kinbara; S Ishiura; S Tomioka; H Sorimachi; S Y Jeong; S Amano; H Kawasaki; B Kolmerer; S Kimura; S Labeit; K Suzuki
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

3.  Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain.

Authors:  Previn Dutt; Cherie N Spriggs; Peter L Davies; Zongchao Jia; John S Elce
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

Review 4.  Structure and physiological function of calpains.

Authors:  H Sorimachi; S Ishiura; K Suzuki
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

5.  MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity.

Authors:  Wu Yang; John Guastella; Jin-Cheng Huang; Yan Wang; Li Zhang; Dong Xue; Minhtam Tran; Richard Woodward; Shailaja Kasibhatla; Ben Tseng; John Drewe; Sui Xiong Cai
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

6.  Characterization of endogenous and recombinant human calpain-10.

Authors:  Biao Dong; Rihe Liu
Journal:  Biochimie       Date:  2008-04-10       Impact factor: 4.079

7.  Electrostatic interactions of domain III stabilize the inactive conformation of mu-calpain.

Authors:  Amaury Fernández-Montalván; Irmgard Assfalg-Machleidt; Dietmar Pfeiler; Hans Fritz; Marianne Jochum; Werner Machleidt
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

8.  Analysis of proteolytic processes and enzymatic activities in the generation of huntingtin n-terminal fragments in an HEK293 cell model.

Authors:  Andrew T N Tebbenkamp; Keith W Crosby; Zoe B Siemienski; Hilda H Brown; Todd E Golde; David R Borchelt
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib.

Authors:  James A MacLeod; Yan Gao; Christine Hall; William J Muller; Taranjit S Gujral; Peter A Greer
Journal:  Oncotarget       Date:  2018-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.